Loading article...
Loading article...
Stream/Area:
-
Subject:
-
Paper ID:
IJSREM51052
Volume:
9 |
6 |
Jun 2025
Pages:
Publication Frequency:
Monthly (12 issues per year)
License:International Journal of Scientific Research in Engineering and Management follows the Creative Commons Attribution 4.0 (CC BY 4.0) License, allowing free use and distribution with proper attribution.
Bacterial infection represents a persistent global health threat, and there is a need for precise and fast diagnostic tools to enhance patient outcomes and fight antimicrobial resistance (AMR). Conventional methods like culture-based identification and biochemical testing are although reliable, but they tend to be time-consuming and insensitive—particularly in patients on antibiotics. In recent years, new diagnostic technologies have been developed, such as rapid DNA sequencing, immuno-biomarkers, mass spectrometry, CRISPR/Cas-based biosensors, biosensing platforms, and artificial intelligence (AI)-based systems. This review systematically assesses these technological innovations, their strengths and limitations, their clinical applications, and their potential future.
KEYWORDS
Publication Date
6/27/2025
Peer Review Type
Double-Blind Peer Review
Review Rounds: 2
Documents
Article Views
0
Total views since publication
PDF Downloads
4
Total downloads since publication
Geographic Reach
5
Digital Preservation: This article is permanently archived on Zenodo and complies with all data preservation standards across major indexing platforms.
Plagiarism Screening
This manuscript has been checked for plagiarism using TurnitinPlagiarismChecker software.
Conflict of Interest
The authors declare no conflict of interest related to this research work.
Funding Information
No funding information available for this research.
Related research in the same subject area
Loading similar articles...